This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

EU Pharmaceutical Law Forum


  • 00
  • 00
  • 00
  • 00
EU Pharmaceutical Law Forum 2024
May 21-23, 2024Steigenberger Wiltcher's, Brussels
EU Pharmaceutical Law Forum 2024
May 21-23, 2024,
Steigenberger Wiltcher's, Brussels

Join Skadden at EU Pharmaceutical Law Forum 2024

You're Invited to EU Pharma Law with an Exclusive 10% Off

We are excited to announce that Skadden will be participating at the EU Pharmaceutical Law Forum on 21-23 May 2024 at the Steigenberger Wiltcher's Hotel, Brussels. And, we are pleased to let you know that as a valued client of Skadden, we have an exclusive 10% discount* for you. Your VIP discount code is: P24SKADDEN

*T&C's Apply

PANEL Merger Control and Expanded Jurisdictional Reach Developments and Strategy

  • Review of recent pharmaceutical merger control cases and authority approach

  • Article 22: the latest on Illumina/ Grail and implications for merger control strategy

  • Review of wider merger control cases: Pfizer/ Seagen and implications of Towercast judgments

  • Comparison of EU developments to global trends in merger control

  • How does merger control fit into overall regulatory scrutiny of the pharmaceutical industry?

  • Practical commercial implications when planning for commercial deals